<!DOCTYPE html SYSTEM "about:legacy-compat">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=windows-1254" />
<meta name="description" content="Hepatit B'den D'ye Hep Güncel" />
<meta name="keywords" content="85, 20., Türkiye, Kronik, Viral, Hepatit, Tanı, ve, Tedavi, Rehberi, 2015, 21., Chen, CJ,, Yang, HI,, Su, J,, et, al., Risk, of, hepatocellular, carcinoma, across, a, biological, gradient, serum, hepatitis, B, virus, DNA, level., JAMA, 2006;295:65–73.), 22., Sorrell, MF,, Belongia, EA,, Costa, Gareen, IF,, Grem, JL,, Inadomi, JM,, National, Institutes, Health, Consensus, Development, Conference, Statement:, management, B., Ann, Intern, Med., Jan, 20, 2009;150(2):104-10), 23., Nebbia, G,, Peppa, D,, Maini, MK., Hepatitis, infection:, current, concepts, and, future, challenges., QJM., Feb, 2012;105(2):109-13., 24., Papatheodoridis, GV,, Cholongitas, E,, Archimandritis, AJ,, Current, Lan, infection, before, after, liver, transplantation., Liver, Int, 2009;29:1294–1305.), 25., Marcellin, P,, Gane, Buti, M,, Regression, cirrhosis, during, treatment, with, tenofovir, disoproxil, fumarate, for, chronic, B:, 5-year, open-label, follow-up, study., Lancet, 2013;, 381:468–475., 26., Bruix, Sherman, M., Management, carcinoma:, an, update., Hepatology, 2011;53:1020–1022., 27., EASL-EORTC, clinical, practice, guidelines:, carcinoma., J, Hepatol, 2012;56:908–943., 28., Omata, Lesmana, LA,, Tateishi, R,, Asian, Pacific, Association, the, Study, consensus, recommendations, on, 2010;4:439–474., 29., Scaglione, SJ,, Lok, AS., Effectiveness, in, practice., Gastroenterology, 2012;142:1360–1368,, e1361., 30., Lau, GK,, Piratvisuth, T,, Luo, KX,, Peginterferon, alfa-2a,, lamivudine,, combination, HBeAg-positive, N, Engl, Med, 2005;352:2682–2695., 31., Bonino, F,, alfa-2a, alone,, lamivudine, two, patients, HBeAg-negative, 2004;351:1206–1217.), 32., Buster, EH,, Flink, HJ,, Cakaloglu, Y,, Sustained, HBeAg, HBsAg, loss, long-term, treated, peginterferon, alpha-, 2b., 2008;135:459–467., 33., response, e, antigen-negative, 3, years, alpha-2a., 2009;, 136:2169–2179,, e2161–2164., 34., Hansen, BE,, Factors, that, predict, antigen-positive, to, peginterferon-alfa., 137:2002–2009., 35., 2004;, 351:1206–1217, 36., Brunetto, MR,, Moriconi, surface, antigen, levels:, guide, sustained, 2009;49:1141–1150., 37., Lampertico, Vigano, Cheroni, C,, IL28B, polymorphisms, interferon-, related, seroclearance, genotype, D, 2013;57:890–896., 38., Chang, TT,, Lai, CL,, Kew, Yoon, S,, Entecavir, up, 5, HBV, Enfeksiyonunda" />
<title>Hepatit B'den D'ye Hep Güncel</title>
<link href="style/fonts.css" type="text/css" rel="stylesheet" />
<link href="style/style.css" type="text/css" rel="stylesheet" />
<script>
CURRENT_PAGE = "97";
</script>
<script type="text/javascript" src="javascript/init.js"></script>
<script type="text/javascript" src="javascript/properties.js"></script>
<script type="text/javascript" src="javascript/seo.js"></script>
<!--[if IE]>
<style type="text/css">
.areaLink{
filter:progid:DXImageTransform.Microsoft.Alpha(opacity=0);}
.areaLink:hover {
filter:progid:DXImageTransform.Microsoft.Alpha(opacity=50);}
</style>
<![endif]--></head>
<body>
<div id="bodyBg" class="bodyBg"></div>
<div id="navigation" class="navigation">
<a id="LeftToolText" class="leftTool" href="page96.html" title="96"><img src="./style/sliderleft.png" style="width: 32px; height: 69px; padding: 10px; float: left;" alt=""></a>
<a id="RightToolText" class="rightTool" href="page98.html" title="98"><img src="./style/sliderright.png" style="width: 32px; height: 69px; padding: 10px; float: left;" alt=""></a>
</div>
<div id="Book" class="divCenter" style="width : 453px;">
<h1>Hepatit B'den D'ye Hep Güncel - page 97</h1>
<div id="Page" class="divPage" style="height :666px; background-color:#FFFFFF;">
<img alt="" src="../common/page-substrates/page0097.png" style="width: 100%; height: 100%;">
<div class="div_items" style="top : 624px; left : 416px; width : 10px; height : 14px; z-index : 0;">
<span class="font1 fontPosition" style="opacity:1;">85</span>
</div>
<div class="div_items" style="top : 56px; left : 62px; width : 13px; height : 13px; z-index : 0;">
<span class="font4 fontPosition" style="opacity:1;">20.</span>
</div>
<div class="div_items" style="top : 56px; left : 84px; width : 216px; height : 13px; z-index : 0;">
<span class="font4 fontPosition" style="opacity:1;">Türkiye Kronik Viral Hepatit Tanı ve Tedavi Rehberi 2015</span>
</div>
<div class="div_items" style="top : 67px; left : 62px; width : 10px; height : 13px; z-index : 0;">
<span class="font4 fontPosition" style="opacity:1;">21.</span>
</div>
<div class="div_items" style="top : 67px; left : 84px; width : 314px; height : 13px; z-index : 0;">
<span class="font4 fontPosition" style="opacity:1;">Chen CJ, Yang HI, Su J, et al. Risk of hepatocellular carcinoma across a biological</span>
</div>
<div class="div_items" style="top : 78px; left : 84px; width : 273px; height : 13px; z-index : 0;">
<span class="font4 fontPosition" style="opacity:1;">gradient of serum hepatitis B virus DNA level. JAMA 2006;295:65–73.)</span>
</div>
<div class="div_items" style="top : 89px; left : 62px; width : 12px; height : 13px; z-index : 0;">
<span class="font4 fontPosition" style="opacity:1;">22.</span>
</div>
<div class="div_items" style="top : 89px; left : 84px; width : 310px; height : 13px; z-index : 0;">
<span class="font4 fontPosition" style="opacity:1;">Sorrell MF, Belongia EA, Costa J, Gareen IF, Grem JL, Inadomi JM, et al. National</span>
</div>
<div class="div_items" style="top : 100px; left : 84px; width : 318px; height : 13px; z-index : 0;">
<span class="font4 fontPosition" style="opacity:1;">Institutes of Health Consensus Development Conference Statement: management</span>
</div>
<div class="div_items" style="top : 111px; left : 84px; width : 222px; height : 13px; z-index : 0;">
<span class="font4 fontPosition" style="opacity:1;">of hepatitis B. Ann Intern Med. Jan 20 2009;150(2):104-10)</span>
</div>
<div class="div_items" style="top : 122px; left : 62px; width : 12px; height : 13px; z-index : 0;">
<span class="font4 fontPosition" style="opacity:1;">23.</span>
</div>
<div class="div_items" style="top : 122px; left : 84px; width : 308px; height : 13px; z-index : 0;">
<span class="font4 fontPosition" style="opacity:1;">Nebbia G, Peppa D, Maini MK. Hepatitis B infection: current concepts and future</span>
</div>
<div class="div_items" style="top : 133px; left : 84px; width : 158px; height : 13px; z-index : 0;">
<span class="font4 fontPosition" style="opacity:1;">challenges. QJM. Feb 2012;105(2):109-13.</span>
</div>
<div class="div_items" style="top : 144px; left : 62px; width : 12px; height : 13px; z-index : 0;">
<span class="font4 fontPosition" style="opacity:1;">24.</span>
</div>
<div class="div_items" style="top : 144px; left : 84px; width : 314px; height : 13px; z-index : 0;">
<span class="font4 fontPosition" style="opacity:1;">Papatheodoridis GV, Cholongitas E, Archimandritis AJ, et al. Current management</span>
</div>
<div class="div_items" style="top : 155px; left : 84px; width : 284px; height : 13px; z-index : 0;">
<span class="font4 fontPosition" style="opacity:1;">of hepatitis B Lan infection before and after liver transplantation. Liver Int</span>
</div>
<div class="div_items" style="top : 166px; left : 84px; width : 82px; height : 13px; z-index : 0;">
<span class="font4 fontPosition" style="opacity:1;">2009;29:1294–1305.)</span>
</div>
<div class="div_items" style="top : 177px; left : 62px; width : 12px; height : 13px; z-index : 0;">
<span class="font4 fontPosition" style="opacity:1;">25.</span>
</div>
<div class="div_items" style="top : 177px; left : 84px; width : 301px; height : 13px; z-index : 0;">
<span class="font4 fontPosition" style="opacity:1;">Marcellin P, Gane E, Buti M, et al. Regression of cirrhosis during treatment with</span>
</div>
<div class="div_items" style="top : 188px; left : 84px; width : 315px; height : 13px; z-index : 0;">
<span class="font4 fontPosition" style="opacity:1;">tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up</span>
</div>
<div class="div_items" style="top : 199px; left : 84px; width : 128px; height : 13px; z-index : 0;">
<span class="font4 fontPosition" style="opacity:1;">study. Lancet 2013; 381:468–475.</span>
</div>
<div class="div_items" style="top : 210px; left : 62px; width : 12px; height : 13px; z-index : 0;">
<span class="font4 fontPosition" style="opacity:1;">26.</span>
</div>
<div class="div_items" style="top : 210px; left : 84px; width : 285px; height : 13px; z-index : 0;">
<span class="font4 fontPosition" style="opacity:1;">Bruix J, Sherman M. Management of hepatocellular carcinoma: an update.</span>
</div>
<div class="div_items" style="top : 221px; left : 84px; width : 123px; height : 13px; z-index : 0;">
<span class="font4 fontPosition" style="opacity:1;">Hepatology 2011;53:1020–1022.</span>
</div>
<div class="div_items" style="top : 232px; left : 62px; width : 11px; height : 13px; z-index : 0;">
<span class="font4 fontPosition" style="opacity:1;">27.</span>
</div>
<div class="div_items" style="top : 232px; left : 84px; width : 279px; height : 13px; z-index : 0;">
<span class="font4 fontPosition" style="opacity:1;">EASL-EORTC clinical practice guidelines: management of hepatocellular</span>
</div>
<div class="div_items" style="top : 243px; left : 84px; width : 156px; height : 13px; z-index : 0;">
<span class="font4 fontPosition" style="opacity:1;">carcinoma. J Hepatol 2012;56:908–943.</span>
</div>
<div class="div_items" style="top : 254px; left : 62px; width : 12px; height : 13px; z-index : 0;">
<span class="font4 fontPosition" style="opacity:1;">28.</span>
</div>
<div class="div_items" style="top : 254px; left : 84px; width : 311px; height : 13px; z-index : 0;">
<span class="font4 fontPosition" style="opacity:1;">Omata M, Lesmana LA, Tateishi R, et al. Asian Pacific Association for the Study of</span>
</div>
<div class="div_items" style="top : 265px; left : 84px; width : 309px; height : 13px; z-index : 0;">
<span class="font4 fontPosition" style="opacity:1;">the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int</span>
</div>
<div class="div_items" style="top : 276px; left : 84px; width : 64px; height : 13px; z-index : 0;">
<span class="font4 fontPosition" style="opacity:1;">2010;4:439–474.</span>
</div>
<div class="div_items" style="top : 287px; left : 62px; width : 12px; height : 13px; z-index : 0;">
<span class="font4 fontPosition" style="opacity:1;">29.</span>
</div>
<div class="div_items" style="top : 287px; left : 84px; width : 303px; height : 13px; z-index : 0;">
<span class="font4 fontPosition" style="opacity:1;">Scaglione SJ, Lok AS. Effectiveness of hepatitis B treatment in clinical practice.</span>
</div>
<div class="div_items" style="top : 298px; left : 84px; width : 174px; height : 13px; z-index : 0;">
<span class="font4 fontPosition" style="opacity:1;">Gastroenterology 2012;142:1360–1368, e1361.</span>
</div>
<div class="div_items" style="top : 309px; left : 62px; width : 12px; height : 13px; z-index : 0;">
<span class="font4 fontPosition" style="opacity:1;">30.</span>
</div>
<div class="div_items" style="top : 309px; left : 84px; width : 283px; height : 13px; z-index : 0;">
<span class="font4 fontPosition" style="opacity:1;">Lau GK, Piratvisuth T, Luo KX, et al. Peginterferon alfa-2a, lamivudine, and</span>
</div>
<div class="div_items" style="top : 320px; left : 84px; width : 268px; height : 13px; z-index : 0;">
<span class="font4 fontPosition" style="opacity:1;">the combination for HBeAg-positive chronic hepatitis B. N Engl J Med</span>
</div>
<div class="div_items" style="top : 331px; left : 84px; width : 90px; height : 13px; z-index : 0;">
<span class="font4 fontPosition" style="opacity:1;">2005;352:2682–2695.</span>
</div>
<div class="div_items" style="top : 342px; left : 62px; width : 10px; height : 13px; z-index : 0;">
<span class="font4 fontPosition" style="opacity:1;">31.</span>
</div>
<div class="div_items" style="top : 342px; left : 87px; width : 316px; height : 13px; z-index : 0;">
<span class="font4 fontPosition" style="opacity:1;">Marcellin P, Lau GK, Bonino F, et al. Peginterferon alfa-2a alone, lamivudine alone,</span>
</div>
<div class="div_items" style="top : 353px; left : 84px; width : 316px; height : 13px; z-index : 0;">
<span class="font4 fontPosition" style="opacity:1;">and the two in combination in patients with HBeAg-negative chronic hepatitis B. N</span>
</div>
<div class="div_items" style="top : 364px; left : 84px; width : 126px; height : 13px; z-index : 0;">
<span class="font4 fontPosition" style="opacity:1;">Engl J Med 2004;351:1206–1217.)</span>
</div>
<div class="div_items" style="top : 375px; left : 62px; width : 12px; height : 13px; z-index : 0;">
<span class="font4 fontPosition" style="opacity:1;">32.</span>
</div>
<div class="div_items" style="top : 375px; left : 84px; width : 302px; height : 13px; z-index : 0;">
<span class="font4 fontPosition" style="opacity:1;">Buster EH, Flink HJ, Cakaloglu Y, et al. Sustained HBeAg and HBsAg loss after</span>
</div>
<div class="div_items" style="top : 386px; left : 84px; width : 311px; height : 13px; z-index : 0;">
<span class="font4 fontPosition" style="opacity:1;">long-term follow-up of HBeAg-positive patients treated with peginterferon alpha-</span>
</div>
<div class="div_items" style="top : 397px; left : 84px; width : 159px; height : 13px; z-index : 0;">
<span class="font4 fontPosition" style="opacity:1;">2b. Gastroenterology 2008;135:459–467.</span>
</div>
<div class="div_items" style="top : 408px; left : 62px; width : 12px; height : 13px; z-index : 0;">
<span class="font4 fontPosition" style="opacity:1;">33.</span>
</div>
<div class="div_items" style="top : 408px; left : 84px; width : 275px; height : 13px; z-index : 0;">
<span class="font4 fontPosition" style="opacity:1;">Marcellin P, Bonino F, Lau GK, et al. Sustained response of hepatitis B e</span>
</div>
<div class="div_items" style="top : 419px; left : 84px; width : 300px; height : 13px; z-index : 0;">
<span class="font4 fontPosition" style="opacity:1;">antigen-negative patients 3 years after treatment with peginterferon alpha-2a.</span>
</div>
<div class="div_items" style="top : 430px; left : 84px; width : 203px; height : 13px; z-index : 0;">
<span class="font4 fontPosition" style="opacity:1;">Gastroenterology 2009; 136:2169–2179, e2161–2164.</span>
</div>
<div class="div_items" style="top : 441px; left : 62px; width : 12px; height : 13px; z-index : 0;">
<span class="font4 fontPosition" style="opacity:1;">34.</span>
</div>
<div class="div_items" style="top : 441px; left : 84px; width : 300px; height : 13px; z-index : 0;">
<span class="font4 fontPosition" style="opacity:1;">Buster EH, Hansen BE, Lau GK, et al. Factors that predict response of patients</span>
</div>
<div class="div_items" style="top : 452px; left : 84px; width : 288px; height : 13px; z-index : 0;">
<span class="font4 fontPosition" style="opacity:1;">with hepatitis B e antigen-positive chronic hepatitis B to peginterferon-alfa.</span>
</div>
<div class="div_items" style="top : 463px; left : 84px; width : 160px; height : 13px; z-index : 0;">
<span class="font4 fontPosition" style="opacity:1;">Gastroenterology 2009; 137:2002–2009.</span>
</div>
<div class="div_items" style="top : 474px; left : 62px; width : 12px; height : 13px; z-index : 0;">
<span class="font4 fontPosition" style="opacity:1;">35.</span>
</div>
<div class="div_items" style="top : 474px; left : 84px; width : 316px; height : 13px; z-index : 0;">
<span class="font4 fontPosition" style="opacity:1;">Marcellin P, Lau GK, Bonino F, et al. Peginterferon alfa-2a alone, lamivudine alone,</span>
</div>
<div class="div_items" style="top : 485px; left : 84px; width : 316px; height : 13px; z-index : 0;">
<span class="font4 fontPosition" style="opacity:1;">and the two in combination in patients with HBeAg-negative chronic hepatitis B. N</span>
</div>
<div class="div_items" style="top : 496px; left : 84px; width : 125px; height : 13px; z-index : 0;">
<span class="font4 fontPosition" style="opacity:1;">Engl J Med 2004; 351:1206–1217</span>
</div>
<div class="div_items" style="top : 507px; left : 62px; width : 12px; height : 13px; z-index : 0;">
<span class="font4 fontPosition" style="opacity:1;">36.</span>
</div>
<div class="div_items" style="top : 507px; left : 84px; width : 316px; height : 13px; z-index : 0;">
<span class="font4 fontPosition" style="opacity:1;">Brunetto MR, Moriconi F, Bonino F, et al. Hepatitis B virus surface antigen levels: a</span>
</div>
<div class="div_items" style="top : 518px; left : 84px; width : 311px; height : 13px; z-index : 0;">
<span class="font4 fontPosition" style="opacity:1;">guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic</span>
</div>
<div class="div_items" style="top : 529px; left : 84px; width : 165px; height : 13px; z-index : 0;">
<span class="font4 fontPosition" style="opacity:1;">hepatitis B. Hepatology 2009;49:1141–1150.</span>
</div>
<div class="div_items" style="top : 540px; left : 62px; width : 10px; height : 13px; z-index : 0;">
<span class="font4 fontPosition" style="opacity:1;">37.</span>
</div>
<div class="div_items" style="top : 540px; left : 84px; width : 316px; height : 13px; z-index : 0;">
<span class="font4 fontPosition" style="opacity:1;">Lampertico P, Vigano M, Cheroni C, et al. IL28B polymorphisms predict interferon-</span>
</div>
<div class="div_items" style="top : 551px; left : 84px; width : 298px; height : 13px; z-index : 0;">
<span class="font4 fontPosition" style="opacity:1;">related hepatitis B surface antigen seroclearance in genotype D hepatitis B e</span>
</div>
<div class="div_items" style="top : 562px; left : 84px; width : 313px; height : 13px; z-index : 0;">
<span class="font4 fontPosition" style="opacity:1;">antigen-negative patients with chronic hepatitis B. Hepatology 2013;57:890–896.</span>
</div>
<div class="div_items" style="top : 573px; left : 62px; width : 12px; height : 13px; z-index : 0;">
<span class="font4 fontPosition" style="opacity:1;">38.</span>
</div>
<div class="div_items" style="top : 573px; left : 84px; width : 292px; height : 13px; z-index : 0;">
<span class="font4 fontPosition" style="opacity:1;">Chang TT, Lai CL, Kew Yoon S, et al. Entecavir treatment for up to 5 years in</span>
</div>
<div class="div_items" style="top : 584px; left : 84px; width : 287px; height : 13px; z-index : 0;">
<span class="font4 fontPosition" style="opacity:1;">patients with hepatitis B e antigen-positive chronic hepatitis B. Hepatology</span>
</div>
<div class="div_items" style="top : 23px; left : 285px; width : 119px; height : 11px; z-index : 0;">
<span class="font5 fontPosition" style="opacity:1;">Kronik HBV Enfeksiyonunda Tedavi</span>
</div>
<div id="PageMenu" class="box">
<div id="boxVersion" class="boxVersion fontVersion">
SEO Version
<div style="position: relative; top:0px; left:0px; overflow: hidden;">
<img src="./style/info.png" style="width: 14px; height:14px; cursor: pointer; position: relative; top: 4px; left:0px;" onclick="javascript:about.action();" alt="">
<div class="balloon" id="infoBalloon">
<div class="arrow"></div>
<a href="javascript:about.action();" class="closeButton" title="Close"></a>
<h2>Warning.</h2>
<p>You are currently viewing the SEO version of <b>!text</b>.<br>It has a number of design and functionality limitations.</p>
<br>
<p>We recommend viewing the <a href="../../../index.html">Flash version</a> or the <a href="index.html">basic HTML version</a> of this publication.</p>
</div>
</div>
</div>
<div id="boxMenu" class="menu fontMenu">
<a id="tocLink" href="toc.html">
Table of Contents
</a>
<span class="fontMenuPadding">|</span>
<a id="fullVersionLink" href="../../../index.html">
Flash Version
</a>
</div>
</div>
</div>
<div style="overflow: hidden;">
<span id="addNavigationLeft" class="addNavigationLeft">
<a href="page1.html" target="_self" title="1">1</a>...,<a href="page87.html" target="_self" title="87">87</a>,<a href="page88.html" target="_self" title="88">88</a>,<a href="page89.html" target="_self" title="89">89</a>,<a href="page90.html" target="_self" title="90">90</a>,<a href="page91.html" target="_self" title="91">91</a>,<a href="page92.html" target="_self" title="92">92</a>,<a href="page93.html" target="_self" title="93">93</a>,<a href="page94.html" target="_self" title="94">94</a>,<a href="page95.html" target="_self" title="95">95</a>,<a href="page96.html" target="_self" title="96">96</a>
</span>
<span id="addNavigationRight" class="addNavigationRight">
<a href="page98.html" target="_self" title="98">98</a>,<a href="page99.html" target="_self" title="99">99</a>,<a href="page100.html" target="_self" title="100">100</a>,<a href="page101.html" target="_self" title="101">101</a>,<a href="page102.html" target="_self" title="102">102</a>,<a href="page103.html" target="_self" title="103">103</a>,<a href="page104.html" target="_self" title="104">104</a>,<a href="page105.html" target="_self" title="105">105</a>,<a href="page106.html" target="_self" title="106">106</a>,<a href="page107.html" target="_self" title="107">107</a>,...<a href="page328.html" target="_self" title="328">328</a>
</span>
</div>
</div>
</body>
</html>